Google TrendCHAMPIONS LEAGUE SCHEDULE (500+) — Champions League Matchday 2: Key stats and what to look out for in every game
The 24/7 Global Portal

World News, Markets & Google Trends

Aggregated real-time headlines, trending Google search queries, and verified dispatches in one single page.

Category:All HeadlinesWorld & GeopoliticsMarkets & EconomyTech & AIPoliticsSearch results for: "Development of novel mult" (30 stories)

Top Headline Story

Insilico Medicine Announces Global R&D Collaboration with Lilly
Lead StoryInsilico Medicineworld
Mar 29

Insilico Medicine Announces Global R&D Collaboration with Lilly

<a href="https://news.google.com/rss/articles/CBMigwFBVV95cUxOMWQyamIxc09USUVta3Q0a3J2WW1SZFgyaUpnUHNCdGJ4ZGZraXhPOExkcVRlQmtmb2w1Z2w5TlExX3dzUDVDX2hSOG50dmpablFBOVdvS09TYXF5Vzd4UmhFWFo5VERHaEE3eDJQSkJxeml3eGFUVTU3RFlEYThWT0FIQQ?oc=5" target="_blank">Insilico Medicine Announces Global R&D Collaboration with Lilly</a>  <font color="#6f6f6f">Insilico Medicine</font>

Real-time search volume
500+21m ago

champions league schedule

Champions League Matchday 2: Key stats and what to look out for in every game

500+31m ago

matthew stone sr

Victims of Pennsylvania mass shooting included pregnant daughter of gunman

500+31m ago

geomagnetic storm aurora visibility northern us

Northern Lights Forecast: Aurora Could Be Visible From These 10 States Monday

5000+51m ago

selma blair

Selma Blair Arrested, Attacks Flight Crew After Trying to Open Plane Door Mid-Air

Search Results for "Development of novel mult"

Updated every 3 minutes via FreeNewsApi, GNews, Currents API & Google News

29 stories displayed
A novel small molecule remyelination therapy for multiple sclerosis
Naturegeneral

A novel small molecule remyelination therapy for multiple sclerosis

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE9oblgyaE5NSi1WOXVmRnFPRmRTSy1xNmUyNTVqT1gtaXNLQTdzRWtrMzlJUkVzNkpOWHlBSmdxTDEwczR2UTRDeHNPRUpCNUh4SnlmUHdlal9QYkpVRmJn?oc=5" target="_blank">A novel small molecule remyelination therapy for multiple sclerosis</a>  <font color="#6f6f6f">Nature</font>

GSK to acquire potential best-in-class T cell-engager (TCE) for multiple myeloma from Chimagen Biosciences
GSKscience

GSK to acquire potential best-in-class T cell-engager (TCE) for multiple myeloma from Chimagen Biosciences

<a href="https://news.google.com/rss/articles/CBMi5wFBVV95cUxQSEFmRVdSR1FKSGw2TzN3R2RnU1o4cjdkckpXSDJMMkVmQzdZVEg4NGFmakJ6R3ZXczhlaG9uS3NoTVUxSlFpZklXMjNSR0t6TmlKS3BvdkFmSU05eFY4TFNFdFlGV052LUpuUlVYam9nNmRNZW1NUVplWFNLbUZFNkpuNVgtT1otc0EwcmhuTUZpbUw0b1UtQTRFcFhwOTd5ZkRhRDlBNDgxRXhkT0FHd3YyaWJ4dmVqZGY2TnQzN0dmMUh2VlJVNHVaemp4UjNGcExVVHdQcnd2X1BPcGx2dTdQNkU1R00?oc=5" target="_blank">GSK to acquire potential best-in-class T cell-engager (TCE) for multiple myeloma from Chimagen Biosciences</a>  <font color="#6f6f6f">GSK</font>

Once in a BlueMoon: Multiple State-Aligned Threat Actors Rapidly Adopt Novel Exploit Chain Using Chrome and Windows Zero-Days
Proofpointtech

Once in a BlueMoon: Multiple State-Aligned Threat Actors Rapidly Adopt Novel Exploit Chain Using Chrome and Windows Zero-Days

<a href="https://news.google.com/rss/articles/CBMixwFBVV95cUxNZWRmdnVfYU9Jb19QV1lnSWMtc1FkbWJDcDVoWGl4NUFDb0ppdjZ4M18zUkZXcGQyeEdUYmxFZ0dkcWphRDdzLVk4QWN0T2wyRENuLVo5MmViYnZpNzlnOXNRZ1J3RmNpREJNYWZyTHJoNnZsVExaZnpGdW0wQXZqZE9oRzJHTkNHMENtdzBaeHdjZ1Z1cmNHanljODNlYmZtZ09icW9RNDZTRmtzaDdVOS1tV25JbVFZOUcwc3NIeUQxSGRVQkg4?oc=5" target="_blank">Once in a BlueMoon: Multiple State-Aligned Threat Actors Rapidly Adopt Novel Exploit Chain Using Chrome and Windows Zero-Days</a>  <font color="#6f6f6f">Proofpoint</font>

Immunic to Host Virtual Relapsing Multiple Sclerosis R&D Day on September 9, 2026
PR Newswireworld

Immunic to Host Virtual Relapsing Multiple Sclerosis R&D Day on September 9, 2026

<a href="https://news.google.com/rss/articles/CBMi0AFBVV95cUxOd3g0MUdsT3hpTXZfTzNlM0o5ZmsyVVpDd2JvTzR2aDRlSDhzOWZZX0FGOFFkZG96OXNtTTZmY214WDY2Y05rb0NvN3A3XzdtRVlpUGhGaUpVdndpTzdkZ1ZYQndhTzYyTG1EMy16U0U2NDgzMmVqeE5vNHF6eWlYZ2RXRGJnY2xHN2VlNFFBMThXY2l6NXMtcmNGVDhfN2FDQVNkZnBRUnV0bWxnQVFKdXNwUXpWVUZZeHlxTmxEX2pIV2o4dGNYS1FPeWx1MXlF?oc=5" target="_blank">Immunic to Host Virtual Relapsing Multiple Sclerosis R&D Day on September 9, 2026</a>  <font color="#6f6f6f">PR Newswire</font>

Rani Therapeutics Announces Research and Development Collaboration with PegBio to Expand Obesity Pipeline Across Multiple Novel Candidates
Yahoo Financeworld

Rani Therapeutics Announces Research and Development Collaboration with PegBio to Expand Obesity Pipeline Across Multiple Novel Candidates

<a href="https://news.google.com/rss/articles/CBMirgFBVV95cUxQLVFfMFRCQ3VFNmh3dWFTa3hELXpMcWZSVnV4dXVMa3VwNWNZSDJ1RURJTkt5aFpuT29JNHBtNWFUdGRVLXhMZUt6QVdJaTNhZU00bWJuenZsdUhPa2V5a09GalZxRE9XMUxNS1k0WWwtMjN1dU9VYzhRNEhSYXhqSTE0QldyWFZJaDd2VEZ5WDE2LTRHV29RVjNmQUlxRi1WdVN5dXdyWXpaQUFWQkE?oc=5" target="_blank">Rani Therapeutics Announces Research and Development Collaboration with PegBio to Expand Obesity Pipeline Across Multiple Novel Candidates</a>  <font color="#6f6f6f">Yahoo Finance</font>

A novel multi-epitope vaccine induces protective and therapeutic immunity against Helicobacter pylori
Naturetech

A novel multi-epitope vaccine induces protective and therapeutic immunity against Helicobacter pylori

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE9PdGFTMXpaNHdXZzBlNzVkcjU2U2NrcG5nU3VVT09DYU9CV0Y3ZUZvYWJVSjk2WDdvel9TYkFFcU8yVTVsaDF6U1FLTXFPVXZfSHJvNmVwWnAzaksyaEJr?oc=5" target="_blank">A novel multi-epitope vaccine induces protective and therapeutic immunity against Helicobacter pylori</a>  <font color="#6f6f6f">Nature</font>

Swiss biotechs advance clinical programs across multiple therapeutic areas
Startuptickertech

Swiss biotechs advance clinical programs across multiple therapeutic areas

<a href="https://news.google.com/rss/articles/CBMisAFBVV95cUxOU19PWWxhc29SckRpQW9GSUJNb3k3SXZlTWx1MHJnNzkxZ3VKZnRjWFczRVBkX2V4RmRBTFdUNEdwNTg1V3VtZ3RhSkpzeUdjTXNHdUpmeURfXzZLSEZhWXZIQzdrZnBMdW8wVHk2d1F4bEMxZDVkbnFqUjRoY1VwbmpheVpwWEtMRmpRWUhnYnBRZjlnN2Y2Vi1QMGhBMDdhZXJMblIxT0w0bndpXzkxbw?oc=5" target="_blank">Swiss biotechs advance clinical programs across multiple therapeutic areas</a>  <font color="#6f6f6f">Startupticker</font>

Development of novel multi-protein chimeric immunogens that protect against infection with the Lyme disease agent, Borreliella burgdorferi
ASM Journalstech

Development of novel multi-protein chimeric immunogens that protect against infection with the Lyme disease agent, Borreliella burgdorferi

<a href="https://news.google.com/rss/articles/CBMiZEFVX3lxTFAzbDBBM0J6M0txOFpBVHBQeWNyZElUaUoxbm5NTUxlUWtVU280aVRYNk1qaS1meExDWjJPSHJjTHZsTHNjUjkzSndxSHZac01ieU1SNmVaNHJrTGdaWDRKRXlQdUU?oc=5" target="_blank">Development of novel multi-protein chimeric immunogens that protect against infection with the Lyme disease agent, Borreliella burgdorferi</a>  <font color="#6f6f6f">ASM Journals</font>

Multi-omics and artificial intelligence for precision drug discovery and potential clinical applications
Naturegeneral

Multi-omics and artificial intelligence for precision drug discovery and potential clinical applications

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE0wR0FVVnY0NXYwaURXUkJPZjVxeHFmZjc2REFWTTk4eU1RdlIxaDhiYkh2TEhKdHVwdnhBalhpU1FjdldrV1k3MUxWdVI5aldHUG5PaFRIWVVLa3V2UlVZ?oc=5" target="_blank">Multi-omics and artificial intelligence for precision drug discovery and potential clinical applications</a>  <font color="#6f6f6f">Nature</font>

Hyperparameter optimization of YOLO using differential evolution, multi-fidelity optimization, and Bayesian optimization
Naturegeneral

Hyperparameter optimization of YOLO using differential evolution, multi-fidelity optimization, and Bayesian optimization

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE51T3VFaHlmbG95d0lwNjNaYlNVZEpUUlk1aV9VeTRPeDZLSmFyMTN6X2h5dU9OdmQwTE1zWlRYd0paM09yZmFucjdfOXFzaHE0aURMLUpwb19OXzlSR0hV?oc=5" target="_blank">Hyperparameter optimization of YOLO using differential evolution, multi-fidelity optimization, and Bayesian optimization</a>  <font color="#6f6f6f">Nature</font>

Designing a multi-epitope subunit vaccine against chikungunya virus using immunoinformatics and molecular simulation approaches
Naturetech

Designing a multi-epitope subunit vaccine against chikungunya virus using immunoinformatics and molecular simulation approaches

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE1WN053MDJEREhVdzc2dC1BRDZHZWItc3hRWllyYmc1REZHREVzb3BwVlFldC1BNlZaWkZ1WC1URGRsYTc0QlBGM05ZMWZJTFJPZWJGb0JselZKbVIyMUFJ?oc=5" target="_blank">Designing a multi-epitope subunit vaccine against chikungunya virus using immunoinformatics and molecular simulation approaches</a>  <font color="#6f6f6f">Nature</font>

In silico design and characterization of a novel multi-epitope mRNA vaccine candidate against Streptococcus pneumoniae
Naturetech

In silico design and characterization of a novel multi-epitope mRNA vaccine candidate against Streptococcus pneumoniae

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE1KSk9UOHpRNFVPdV82ZVlXUElpMnB2RnoteS1xV1l6RXhoWlFES1NhcEllQWdYQXR5akdKTHpzaUV0Rkd5YjRjMjhicExza1E3SVpRZ0JFOWx0dldNMklF?oc=5" target="_blank">In silico design and characterization of a novel multi-epitope mRNA vaccine candidate against Streptococcus pneumoniae</a>  <font color="#6f6f6f">Nature</font>

The evolution of object detection from CNNs to transformers and multi-modal fusion
Naturegeneral

The evolution of object detection from CNNs to transformers and multi-modal fusion

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFBOeHN2MkdFc21hNWRBMWdmMXZRUnRPcjNJUnNYYVlIM0J2N0s2YkN2WjlzSC16MnplNGdEMzhGV1NUM3NPTDMzd3paQ3JaN0FyZ2FvR1FMc3JUN0NYSWZB?oc=5" target="_blank">The evolution of object detection from CNNs to transformers and multi-modal fusion</a>  <font color="#6f6f6f">Nature</font>

Development of a novel multi-epitope subunit mRNA vaccine candidate to combat Acinetobacter baumannii
Natureworld

Development of a novel multi-epitope subunit mRNA vaccine candidate to combat Acinetobacter baumannii

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE5qaWVlUE8zbzNMVC1fYXZLZXBLVC1WY1VMTVNxOGZwSWtwRW9TenJsOGtuZTJRYXh0V3U3R1I3OVlCa1lWRXM4eHhrOUI2cWNYcU93VWs1TEpaVzNDUmNz?oc=5" target="_blank">Development of a novel multi-epitope subunit mRNA vaccine candidate to combat Acinetobacter baumannii</a>  <font color="#6f6f6f">Nature</font>

Development of a multi-epitope vaccine against Helicobacter pylori using a novel saRNA technology through an immunoinformatics approach | Scientific Reports
Naturetech

Development of a multi-epitope vaccine against Helicobacter pylori using a novel saRNA technology through an immunoinformatics approach | Scientific Reports

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE0zZGdSTmlXcW1TN0xJN1lSU2tBSkpwSE1Sa0VkWVF2QTRPaDBXMno5emozUlpxbEY3QThvT2xERDhZVHFWS1l0OEVvS0ZRS3ZYdGRYZUtRQUdBNm1ZSVRF?oc=5" target="_blank">Development of a multi-epitope vaccine against Helicobacter pylori using a novel saRNA technology through an immunoinformatics approach | Scientific Reports</a>  <font color="#6f6f6f">Nature</font>

Development of a novel non-invasive biomarker panel for hepatic fibrosis in MASLD
Naturegeneral

Development of a novel non-invasive biomarker panel for hepatic fibrosis in MASLD

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE5FWkt1eTV6VnBWaVk2WlBYOUJWWkNVTmFOUVZoMVVETFdFcUc3amJCUWNqNUh5ZFJxLUpLeS1QcGtab21nZUdXdUNyeGdnLW1vT001ZmhKazhpa2x0VHo4?oc=5" target="_blank">Development of a novel non-invasive biomarker panel for hepatic fibrosis in MASLD</a>  <font color="#6f6f6f">Nature</font>

Development of a novel multiepitope vaccine against Menangle virus (MenV) using in-silico approaches by targeting its transmembrane proteins
Naturetech

Development of a novel multiepitope vaccine against Menangle virus (MenV) using in-silico approaches by targeting its transmembrane proteins

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFBrSFAyd2U4MFVsSzQwMWZDWmo3TlBnTVVmR3RfbnFMTm54MV9ObXRqSnR5a0RiclZyYUx1YWw3eVBILXdESElBeEtNdDgweUZNX3JPdmlFMklpOWt5RlJn?oc=5" target="_blank">Development of a novel multiepitope vaccine against Menangle virus (MenV) using in-silico approaches by targeting its transmembrane proteins</a>  <font color="#6f6f6f">Nature</font>

Development of a novel humanized gut-brain axis model as a tool toward personalized nutrition
Naturetech

Development of a novel humanized gut-brain axis model as a tool toward personalized nutrition

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE9Ycnoxb0FKUW1NRnhUZVoweWNJRjRrdEF6RzZfR09kUTVadTI3eDk0NVMzZGhMc2tPWWsyM0tDUVp0QW9sWkZsekpmTXhFT2lLTVBIb1J4RUxMYjd3MVJn?oc=5" target="_blank">Development of a novel humanized gut-brain axis model as a tool toward personalized nutrition</a>  <font color="#6f6f6f">Nature</font>

Recent advances in Alzheimer’s disease: mechanisms, clinical trials and new drug development strategies
Naturegeneral

Recent advances in Alzheimer’s disease: mechanisms, clinical trials and new drug development strategies

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFB0NlUzblFkUXhPMWhMOVBpajRhbm1UVWZSYjg3WGxzV0pCRlEwRzRtcldTLVphMm5NZ1pVRGR3cEttY3pCQV9yU3l1cndqQTBSeFlGQjZrbFl4dFdOVWkw?oc=5" target="_blank">Recent advances in Alzheimer’s disease: mechanisms, clinical trials and new drug development strategies</a>  <font color="#6f6f6f">Nature</font>

Targeting ferroptosis opens new avenues for the development of novel therapeutics
Naturegeneral

Targeting ferroptosis opens new avenues for the development of novel therapeutics

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE01cEgyeHBxUWt1a01odVc1RUFZVG1jbzZKdFJ1aFVaOEdsNEg5ZUdDRkxWTTdwUU1EcEdOTEZ2V2FtY29qVnNyNGNXRThWTWtFek9PRmZUVnA3Q1VQOTA0?oc=5" target="_blank">Targeting ferroptosis opens new avenues for the development of novel therapeutics</a>  <font color="#6f6f6f">Nature</font>

€1.1M grant moves novel skin patch for MS closer to first human trial
Multiple Sclerosis News Todaygeneral

€1.1M grant moves novel skin patch for MS closer to first human trial

<a href="https://news.google.com/rss/articles/CBMiwwFBVV95cUxPVlVpWTRwT0NnN3Z0ZHVHa3NFRXJRTHBYelRJeXFnUUFZUHFtbjNRb2prSHdsNUpCRlJNVk9OQUlkdVYxZXJIUDV3UG9CSEN0OExaV2ZKaWhnMzh4RkxjeS1DVEdwRGxUWEZNanRSVEZlQkpQOEdrZWQzNHFWdWsydVZOTWN5a1J3WGRhNHVXRGhidVZDb1BBcW50SGlJcU8tY2hmcEZ5bzNDQkVsLXRRdHRnYW9fVFR6Q0U1NmZtQjEwTGM?oc=5" target="_blank">€1.1M grant moves novel skin patch for MS closer to first human trial</a>  <font color="#6f6f6f">Multiple Sclerosis News Today</font>

New clinical trial design in precision medicine: discovery, development and direction
Naturegeneral

New clinical trial design in precision medicine: discovery, development and direction

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE04QktKWmp5aXNlNm9uU29kSl9CcHBMa2Z1aTRvLXpITG1obTV0VEROUXdhYWp4LTVGeFpFbER0WXM1TUxLVG55NFBQM094V3lKMWNFWWl4RFNvTkZSTGEw?oc=5" target="_blank">New clinical trial design in precision medicine: discovery, development and direction</a>  <font color="#6f6f6f">Nature</font>

Novel machine learning driven design strategy for high strength Zn Alloys optimization with multiple constraints
Naturetech

Novel machine learning driven design strategy for high strength Zn Alloys optimization with multiple constraints

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFBVRzRKWnAwWjA4anNMdTF4aDRBWWlXVElPaFRUQUtYeGFFU2V4MVg3ZjdLd1hyYkRxWjBvbHI2emJFR3gyWnhhR0F3M0tBZEtqNUdwb0F4U3hCVmRTa1JR?oc=5" target="_blank">Novel machine learning driven design strategy for high strength Zn Alloys optimization with multiple constraints</a>  <font color="#6f6f6f">Nature</font>

A novel in-vitro expression assay by LC/MS/MS enables multi-antigen mRNA vaccine characterization
Naturegeneral

A novel in-vitro expression assay by LC/MS/MS enables multi-antigen mRNA vaccine characterization

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFBwdXZxRGFSQjluWDEybWJ1VXYtOENRMGdJWWVGY1NEX29rVTFUeDgwR0lrUWh0Zm94RDBCeFpLU0hMRXBJYjZjZWZNVUUxN3ZQamRTZzFYS3VQOWY2QU5N?oc=5" target="_blank">A novel in-vitro expression assay by LC/MS/MS enables multi-antigen mRNA vaccine characterization</a>  <font color="#6f6f6f">Nature</font>

Multiple sclerosis: molecular pathogenesis and therapeutic intervention | Signal Transduction and Targeted Therapy
Naturegeneral

Multiple sclerosis: molecular pathogenesis and therapeutic intervention | Signal Transduction and Targeted Therapy

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFBQMFNQNmgzckJRZWtraDhfUjhJY1EzVWFwSU50azNlbTczTXlvRnRjTWdhY2lGaGRIeGcxMFM1RkNXZ1FnaUJBUGlnclkyMDlleXkyVDg5YkZWcHJrRzRj?oc=5" target="_blank">Multiple sclerosis: molecular pathogenesis and therapeutic intervention | Signal Transduction and Targeted Therapy</a>  <font color="#6f6f6f">Nature</font>

Genome-wide meta-analysis identifies novel risk loci for uterine fibroids within and across multiple ancestry groups
Naturegeneral

Genome-wide meta-analysis identifies novel risk loci for uterine fibroids within and across multiple ancestry groups

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE9tVnhrNmQtRVNzSy01bl9BQ3o0S3hnN1NLOUhYdGlKb2o0VVV3Y1o2Z2VUejZXWlBaRWtZMGRkeHczMFlyOVJOYzdwV3VIeFF0UEs1bk5qVnY3VjZZWlNv?oc=5" target="_blank">Genome-wide meta-analysis identifies novel risk loci for uterine fibroids within and across multiple ancestry groups</a>  <font color="#6f6f6f">Nature</font>

GPRC5D as a novel target for the treatment of multiple myeloma: a narrative review | Blood Cancer Journal
Naturegeneral

GPRC5D as a novel target for the treatment of multiple myeloma: a narrative review | Blood Cancer Journal

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFByWmd0ZWZELW1OdUpBeEgtUlA3RUhSeWJpZGNhenQ1QUxlNW0tNWtzYkJ1UTRmUUlQM1VnNnM3S2liMGNPS0RLVG9oS2ltR0dMdDRDdnNabl9VeTdhdU9N?oc=5" target="_blank">GPRC5D as a novel target for the treatment of multiple myeloma: a narrative review | Blood Cancer Journal</a>  <font color="#6f6f6f">Nature</font>

Generation and validation of a novel multitarget small molecule in glioblastoma
Naturegeneral

Generation and validation of a novel multitarget small molecule in glioblastoma

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFBZdFBOWFR4NWZFNjI3QWpHY09BNk1mWGhWR1QxUmtrLWMtMHFqcnNaQ0ZLTEM4a2IxWk9LekplMGhmeFEzWnA0RnZIVWZKdGlCemowMHRhZ3h3bmRoRGdF?oc=5" target="_blank">Generation and validation of a novel multitarget small molecule in glioblastoma</a>  <font color="#6f6f6f">Nature</font>

Advancing target discovery through disease-specific integration of multi-modal target identification models and comprehensive benchmarking system | Scientific Reports
Naturegeneral

Advancing target discovery through disease-specific integration of multi-modal target identification models and comprehensive benchmarking system | Scientific Reports

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFBPQ2NXd2lxaWhTLTJ6YS1TZi1zem1GWU1BdGI4aUY4ZXZkYS1oLWlkYmpqd1lVazZqVm5OVERoUFdnZ2dLMmJSMVBxcnZFdkFvSm80MkhwNHV1SjBnVXpr?oc=5" target="_blank">Advancing target discovery through disease-specific integration of multi-modal target identification models and comprehensive benchmarking system | Scientific Reports</a>  <font color="#6f6f6f">Nature</font>

"Development of novel mult" — Live Google News Trends & Headlines